Ladenburg Thalmann Financial Services’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio OSIR Stock Details OSIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-500	Closed	-$6K	–	5577
2018 Q3	$6K	Buy	+500	New	+$5K	﹤0.01%	4568
2017 Q1	–	Sell	-400	Closed	-$2K	–	5164
2016 Q4	$2K	Hold	400	–	–	﹤0.01%	4607
2016 Q3	$2K	Sell	400 -342	-46%	-$1.75K	﹤0.01%	4574
2016 Q2	$4K	Hold	742	–	–	﹤0.01%	4265
2016 Q1	$4K	Buy	742 +342	+86%	+$2.39K	﹤0.01%	4233
2015 Q4	$4K	Sell	400 -131	-25%	-$1.78K	﹤0.01%	4206
2015 Q3	$9K	Buy	531 +31	+6%	+$598	﹤0.01%	3643
2015 Q2	$10K	Buy	500 +100	+25%	+$1.77K	﹤0.01%	3724
2015 Q1	$7K	Hold	400	–	–	﹤0.01%	3872
2014 Q4	$6K	Buy	+400	New	+$5.36K	﹤0.01%	3710

Other funds holding OSIR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Cloverdale Capital Management Dallas, Texas $135M AUM 13.89% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

QS Investors New York $8.47B AUM 30.71% 1-Year Est. Return

EGI

EAM Global Investors Solana Beach, California $47.1M AUM 320.45% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

Ladenburg Thalmann Financial Services's OSIR Position: Q4 2018 in Review

Ladenburg Thalmann Financial Services sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q4 2018, closing a stake of 500 shares — an estimated $6K sold.

Ladenburg Thalmann Financial Services first reported a position in OSIR in Q4 2014 and held it in 10 quarters. The position peaked at $10K in Q2 2015. 46 funds tracked by Wall St. Rank hold OSIR as of Q4 2018.

Ladenburg Thalmann Financial Services reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
Ladenburg Thalmann Financial Services sold 500 Osiris Therapeutics, Inc. Common Stock shares in Q4 2018, an estimated $6K.
Ladenburg Thalmann Financial Services first reported a position in Osiris Therapeutics, Inc. Common Stock in Q4 2014 and held it in 10 quarters.
Ladenburg Thalmann Financial Services's Osiris Therapeutics, Inc. Common Stock position peaked at $10K in Q2 2015.
46 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q4 2018.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2018, filed 14 Feb 2019.